Navigation Links
Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
Date:12/6/2007

ssure that the necessary audio applications are downloaded and installed. These programs can be obtained at no charge to the user.

A replay of the call will be available two hours after the completion of the call at (888) 286-8010 in the U.S., ((617) 801-6888 for international callers), pass code 74113063. The replay will be available through Monday, December 24, 2007.

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative cancer therapeutics. Vion has two agents in clinical trials. Cloretazine(R) (VNP40101M), a unique alkylating agent, is being evaluated in a Phase II pivotal trial as a single agent in elderly patients with previously untreated de novo poor-risk acute myelogenous leukemia. Clinical trials of Cloretazine(R) (VNP40101M) as a single agent in small cell lung cancer, with temozolomide in brain tumors, and with hematopoietic cell transplantion in advanced hematologic malignancies, are also being conducted. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at http://www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, delayed or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies or clinical trials are not predictive of safety and efficacy results in later clinical trials, the need for additional research and testing, the potential inability to secure external sources of funding t
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... NxStage Medical, Inc. (Nasdaq: NXTM ), a ... Jeffrey H. Burbank , Chief Executive Officer, will present at ... Boston, MA on Thursday, May 7 th ... event will be made available at http://ir.nxstage.com   at ... NxStage Medical, Inc. (Nasdaq: NXTM ) is ...
(Date:4/27/2015)... Boston Scientific Corporation (NYSE: BSX ... leading software-driven medical technology company that helps improve ... provides patients and physicians a comprehensive portfolio for ... to treat a variety of disorders, and most ... such as Parkinson,s disease (PD), dystonia, and essential ...
(Date:4/27/2015)... 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... treatments for human disease, will release its first quarter ... the financial markets close.  Lexicon management will hold a ... and financial results for the first quarter 2015 at ... The dial-in number for the conference call is ...
Breaking Medicine Technology:NxStage to Present at the 40th Annual Deutsche Bank Securities Health Care Conference 2Boston Scientific Announces Strategic Collaboration With Brainlab AG 2Boston Scientific Announces Strategic Collaboration With Brainlab AG 3Boston Scientific Announces Strategic Collaboration With Brainlab AG 4Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015 2
...  BioInformatics, LLC announces the pending release of three Q4 ... & Brand Assessment (#10-006) Exploring Structural Biology:  Tools ... Structure (#10-004) Genomic Technologies:  Market Insights for Life ... who provide product and services to these three rapidly ...
... Oct. 14 Octapharma USA ... Grants Program , which supports clinical or pre-clinical research ... therapy, intensive care and emergency medicine. The application deadline ... , one of the largest human protein products manufacturers ...
Cached Medicine Technology:BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 2BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 3BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 4Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies 2
(Date:4/27/2015)... "Understanding Mental Disorders: Your Guide to the DSM-5®" ... Publishing, a division of the American Psychiatric Association. The ... Press Club in Washington, D.C.. The launch event will ... Paul Summergrad, MD. Guest speakers will include Former Congressman ... book; Paul Gionfriddo, President and CEO of Mental Health ...
(Date:4/27/2015)... April 27, 2015 UC Davis ... molecular basis of an inherited disorder that historically ... also arises in other populations of Semitic descent, ... series of elegant experiments, the researchers uncovered the ... leukodystrophy that is an incurable and progressively fatal ...
(Date:4/27/2015)... Fitness expert Samir Becic, four-time No. ... health and fitness revolution, teaming up with several celebrities ... several years, Houston, the fourth largest city in America, ... in America. With help from his friends, Becic aims ... the fittest and healthiest cities in the nation. , ...
(Date:4/27/2015)... Based in the Twin Cities of Minneapolis and ... insurance marketing organizations in the country focused on delivering ... as well as employer sponsored ancillary benefits. Spending two ... opportunity to consult with disability insurance carriers, helping to ... , An example of these programs include the most ...
(Date:4/27/2015)... April 27, 2015 On May 5, people ... ask their social media friends around the world to join ... asthma. , May 5 is World Pulmonary Hypertension Day ... leader in the global PH community, will take part in ... blood pressure of the lungs. PH is an increase in ...
Breaking Medicine News(10 mins):Health News:American Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook “Understanding Mental Disorders” 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 3Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 4Health News:Houston Celebrities Take a Stand and Rebel Against Obesity 2Health News:Simplified Solutions Now Makes Disability Insurance Business With Secura Consultants Even Easier! 2Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 2Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 3
... Interoperability within ... Healthcare ... Technologies,Inc., a leading provider of integrated electronic health record ... the Healthcare Enterprise (IHE) Connectathon in Chicago.,The Connectathon, as ...
... Every Step Counts Organization in,association with Clear Channel ... will continue its efforts to celebrate survivors of,domestic ... "Walk In,Her Shoes" 2008, a unique designer shoe ... and Atlanta. Designer shoes featured in "Walk In ...
... electronic medical ... ... CERN ) and Hill-Rom, an operating company of Hillenbrand Industries,(NYSE: ... integrate their technologies to improve and coordinate healthcare,delivery, featuring Hill-Rom intelligent ...
... ... Information Mobility, PORTLAND, Ore., ... connectivity solutions, today announced the,first public demonstration of secure messaging ... HIMSS,(Healthcare Information and Management Systems Society) Conference. Connect,IQ(TM) for HealthVault ...
... Managed Care Contracts Provide 200,000 Members with In-network Access to ... ... MedCath Corporation,(Nasdaq: MDTH ), TexSAn Heart Hospital and the ... agreements with,Blue Cross and Blue Shield of Texas (BCBSTX)., The ...
... Supply chain management system enhanced to support multifaceted hospital, ... ... organization, ORLANDO, Fla., Feb. 25 HIMSS ,08 ... of system solutions to acute,healthcare facilities, today introduced its ...
Cached Medicine News:Health News:Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 2Health News:Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 3Health News:Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase 4Health News:Shoe Therapy Helps Survivors Celebrate Life After Abuse 2Health News:Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery 2Health News:Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery 3Health News:Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery 4Health News:Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery 5Health News:Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery 6Health News:Kryptiq and Microsoft to Showcase Unprecedented Connectivity Between Consumers and Their Doctors at HIMSS '08 2Health News:Kryptiq and Microsoft to Showcase Unprecedented Connectivity Between Consumers and Their Doctors at HIMSS '08 3Health News:TexSAn Heart Hospital Signs Agreement with Blue Cross and Blue Shield of Texas 2Health News:Hospital Environments Increase Staff Efficiency and Patient Safety With Omnicell OptiFlex(TM) SS 9.0 2Health News:Hospital Environments Increase Staff Efficiency and Patient Safety With Omnicell OptiFlex(TM) SS 9.0 3
... The Brasseler USA™ Battery Packs contain ... age have a great impact upon battery ... is necessary. Any deviation from these recommendations ... are sensitive to heat. Any exposure of ...
Pneumatic High-speed Drill, Throttleless, 90k Rpm, Microaire Connector....
Pneumatic oscillating saw, 35k cpm, available with various hose connector styles....
Pneumatic micro reciprocating saw, 15k cpm, available with various hose connector styles....
Medicine Products: